Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Jan 25, 2026
approval
CLOZAPINE — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 15, 2026
approval
ALVAIZ (ELTROMBOPAG CHOLINE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 15, 2026
approval
OXALIPLATIN — FDA approval
Teva Pharmaceuticals USA Inc
→
Jan 13, 2026
device 510k
Kossan International Sdn Bhd — Non-sterile Powder Free Nitrile Examination Glove, Dual Color (White-Green), Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Xylazine HCl, and Simulated Gastric Acid; Non-sterile Powder Free Nitrile Examination Glove, Dual Color (White-Blue), Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Xylazine HCl, and Simulated Gastric Acid (510k cleared)
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
FENTANYL CITRATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 8, 2025
approval
ESTRADIOL — FDA approval
estradiol ER
→
Nov 26, 2025
recall
Park Avenue Compounding recall (Cls II)
Teva Pharmaceuticals USA Inc
→
Nov 18, 2025
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 17, 2025
device 510k
Mercator Medical (Thailand), Ltd. — Powder Free Nitrile Patient Examination Glove, Blue colored, Non-sterile Tested for Use with Chemotherapy Drugs and Fentanyl Citrate; Powder Free Nitrile Patient Examination Glove, Black colored, Non-sterile Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (510k cleared)
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 14, 2025
approval
ARIPIPRAZOLE — FDA approval
Teva Pharmaceuticals USA Inc
→